• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑源性神经营养因子、血管内皮生长因子、肿瘤坏死因子-α 和 S100B 与慢性药物治疗精神分裂症患者认知障碍的相关性。

Correlation of BDNF, VEGF, TNF-α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients.

机构信息

Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand.

Department of Psychiatry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Neuropsychopharmacol Rep. 2022 Sep;42(3):281-287. doi: 10.1002/npr2.12261. Epub 2022 Jun 22.

DOI:10.1002/npr2.12261
PMID:35733332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9515706/
Abstract

Cognitive impairment is a prominent cause of disability in schizophrenia. Although antipsychotic drugs can rescue the psychotic symptoms, the cognitive impairments persist, with no treatment available. Alterations of BDNF, VEGF, TNF-α, and S100B have been linked to cognitive impairment in several neurological disorders. However, it remains unclear whether their levels are correlated with the cognitive functions of schizophrenia patients. Forty-one chronic, medicated schizophrenia patients were included in this study. Enzyme-linked, immunosorbent assays were used to measure the serum concentrations of BDNF, VEGF, TNF-α, and S100B. Associations between serum protein levels and various domains of the cognitive functions of the schizophrenia patients were observed. We found significant, positive correlations between serum BDNF and the processing speed and attention levels of the patients. Serum VEGF was also positively correlated with their memory and learning functions. In contrast, serum S100B and TNF-α were negatively correlated with the processing speed and attention of the schizophrenia patients. The findings warrant further investigation of these molecules as potential prognostic markers or treatment targets for cognitive impairment in schizophrenia patients.

摘要

认知障碍是精神分裂症致残的主要原因。虽然抗精神病药物可以挽救精神病症状,但认知障碍仍然存在,而且没有有效的治疗方法。BDNF、VEGF、TNF-α 和 S100B 的改变与几种神经紊乱中的认知障碍有关。然而,它们的水平是否与精神分裂症患者的认知功能相关仍然不清楚。本研究纳入了 41 名慢性、用药的精神分裂症患者。采用酶联免疫吸附试验检测血清 BDNF、VEGF、TNF-α 和 S100B 浓度。观察了血清蛋白水平与精神分裂症患者认知功能各领域之间的关系。我们发现血清 BDNF 与患者的处理速度和注意力呈显著正相关。血清 VEGF 也与他们的记忆和学习功能呈正相关。相反,血清 S100B 和 TNF-α 与精神分裂症患者的处理速度和注意力呈负相关。这些发现表明这些分子作为精神分裂症患者认知障碍的潜在预后标志物或治疗靶点值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44da/9515706/2e69d50bdc1a/NPR2-42-281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44da/9515706/2e69d50bdc1a/NPR2-42-281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44da/9515706/2e69d50bdc1a/NPR2-42-281-g002.jpg

相似文献

1
Correlation of BDNF, VEGF, TNF-α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients.脑源性神经营养因子、血管内皮生长因子、肿瘤坏死因子-α 和 S100B 与慢性药物治疗精神分裂症患者认知障碍的相关性。
Neuropsychopharmacol Rep. 2022 Sep;42(3):281-287. doi: 10.1002/npr2.12261. Epub 2022 Jun 22.
2
Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.奥氮平对认知功能障碍的代谢性不良反应:脑源性神经营养因子与肿瘤坏死因子-α之间的可能关系。
Psychoneuroendocrinology. 2017 Jul;81:138-143. doi: 10.1016/j.psyneuen.2017.04.014. Epub 2017 Apr 27.
3
Interaction of BDNF with cytokines in chronic schizophrenia.脑源性神经营养因子与慢性精神分裂症中细胞因子的相互作用。
Brain Behav Immun. 2016 Jan;51:169-175. doi: 10.1016/j.bbi.2015.09.014. Epub 2015 Sep 25.
4
Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.接受非典型抗精神病药物单一疗法治疗的日本慢性精神分裂症患者血清脑源性神经营养因子、血浆儿茶酚胺代谢产物、细胞因子、认知功能与临床症状之间的关系
World J Biol Psychiatry. 2017 Aug;18(5):401-408. doi: 10.1080/15622975.2016.1212172. Epub 2016 Aug 15.
5
Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics.不同抗精神病药物治疗的精神分裂症患者血清脑源性神经营养因子与认知障碍的相关性存在性别差异。
J Psychiatr Res. 2021 Jun;138:492-499. doi: 10.1016/j.jpsychires.2021.04.026. Epub 2021 Apr 30.
6
Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.精神分裂症认知障碍的外周炎症和神经营养生物标志物:荟萃分析。
Psychol Med. 2019 Sep;49(12):1971-1979. doi: 10.1017/S0033291719001685. Epub 2019 Jul 9.
7
Increased serum S100B in never-medicated and medicated schizophrenic patients.未用药和用药精神分裂症患者血清 S100B 升高。
J Psychiatr Res. 2010 Dec;44(16):1236-40. doi: 10.1016/j.jpsychires.2010.04.023. Epub 2010 May 26.
8
The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure.精神分裂症患者在最低抗精神病药物暴露下的微小 RNA-195-BDNF 通路和认知缺陷。
Transl Psychiatry. 2021 Feb 8;11(1):117. doi: 10.1038/s41398-021-01240-x.
9
Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.认知功能障碍与未经药物治疗的急性复发精神分裂症患者血清 S100B 浓度升高相关。
Psychiatry Res. 2017 Jan;247:6-11. doi: 10.1016/j.psychres.2016.09.029. Epub 2016 Sep 22.
10
The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.炎症和血脑屏障损伤的选定标志物对短暂性脑缺血发作预后的重要性。
J Physiol Pharmacol. 2019 Apr;70(2). doi: 10.26402/jpp.2019.2.04. Epub 2019 Jul 22.

引用本文的文献

1
Relationship between reduced serum ceruloplasmin levels and executive dysfunction in hospitalized schizophrenia patients.住院精神分裂症患者血清铜蓝蛋白水平降低与执行功能障碍之间的关系。
Front Psychiatry. 2025 Aug 14;16:1618147. doi: 10.3389/fpsyt.2025.1618147. eCollection 2025.
2
The role of TNF signaling pathway in post-stroke cognitive impairment: a systematic review.肿瘤坏死因子信号通路在中风后认知障碍中的作用:一项系统综述。
Ann Med. 2025 Dec;57(1):2543519. doi: 10.1080/07853890.2025.2543519. Epub 2025 Aug 8.
3
Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation.

本文引用的文献

1
Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders.靶向 S100B 蛋白作为替代生物标志物及其在各种神经疾病中的作用。
Curr Neuropharmacol. 2021;19(2):265-277. doi: 10.2174/1570159X18666200729100427.
2
The Relation of Brain-Derived Neurotropic Factor (BDNF) Serum Level to Sub-Domain Cognitive Functions of Indonesian Schizophrenia Patients Measured by MoCA-Ina.脑源性神经营养因子(BDNF)血清水平与通过印尼版蒙特利尔认知评估量表(MoCA-Ina)测量的印尼精神分裂症患者亚领域认知功能的关系。
Open Access Maced J Med Sci. 2019 Dec 30;7(23):4053-4058. doi: 10.3889/oamjms.2019.705. eCollection 2019 Dec 15.
3
炎症水平高的精神分裂症患者尸检人类中脑中脑源性神经营养因子(BDNF)营养能力降低的转录证据。
Transl Psychiatry. 2025 May 7;15(1):162. doi: 10.1038/s41398-025-03359-7.
4
Higher plasma neurofilament-light chain concentration in drug-resistant epilepsy.耐药性癫痫患者血浆神经丝轻链浓度较高。
Brain Commun. 2025 Mar 11;7(2):fcaf108. doi: 10.1093/braincomms/fcaf108. eCollection 2025.
5
Light Treatment Ameliorates Sub-chronic MK-801-Induced Cognitive Deficits in Mice Through Up-regulating BDNF/p-CREB/p-ERK Signaling Pathway.光照疗法通过上调脑源性神经营养因子/磷酸化环磷腺苷反应元件结合蛋白/磷酸化细胞外信号调节激酶信号通路改善亚慢性MK-801诱导的小鼠认知缺陷。
Mol Neurobiol. 2025 May;62(5):5947-5960. doi: 10.1007/s12035-024-04653-z. Epub 2024 Dec 14.
6
The Interrelationships between Cytokines and Schizophrenia: A Systematic Review.细胞因子与精神分裂症的相互关系:系统综述。
Int J Mol Sci. 2024 Aug 3;25(15):8477. doi: 10.3390/ijms25158477.
7
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia.血清基质金属蛋白酶-2 和肿瘤坏死因子-α 水平升高与男性治疗抵抗和慢性药物治疗精神分裂症患者的临床症状的相关性。
BMC Psychiatry. 2024 Mar 1;24(1):173. doi: 10.1186/s12888-024-05621-6.
8
Effects of auriculotherapy on anxiety and biomarkers in Primary Health Care: a clinical trial.耳针疗法对初级保健中焦虑和生物标志物的影响:一项临床试验。
Rev Bras Enferm. 2023 Dec 4;76(6):e20220728. doi: 10.1590/0034-7167-2022-0728pt. eCollection 2023.
9
Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review.五种主要精神疾病中的外周S100B蛋白水平:一项系统评价
Brain Sci. 2023 Sep 16;13(9):1334. doi: 10.3390/brainsci13091334.
10
Serum Biomarkers to Mild Cognitive Deficits in Children and Adolescents.儿童和青少年轻度认知障碍的血清生物标志物。
Mol Neurobiol. 2023 Dec;60(12):7080-7087. doi: 10.1007/s12035-023-03536-z. Epub 2023 Aug 1.
Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits.
精神分裂症的炎症与阴性症状:对奖赏处理和动机缺陷的影响
Front Psychiatry. 2020 Feb 20;11:46. doi: 10.3389/fpsyt.2020.00046. eCollection 2020.
4
Cytokine Alterations in Schizophrenia: An Updated Review.精神分裂症中的细胞因子改变:最新综述
Front Psychiatry. 2019 Dec 6;10:892. doi: 10.3389/fpsyt.2019.00892. eCollection 2019.
5
Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels.缓解期首发精神分裂症的神经认知和社会认知:与 VEGF 血清水平的相关性。
BMC Psychiatry. 2019 Dec 16;19(1):403. doi: 10.1186/s12888-019-2397-8.
6
Brain-derived neurotrophic factor and schizophrenia.脑源性神经营养因子与精神分裂症
Psychiatr Genet. 2019 Oct;29(5):200-210. doi: 10.1097/YPG.0000000000000237.
7
Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophrenia.脑源性神经营养因子与细胞因子在慢性精神分裂症患者执行功能障碍中的相互作用。
Psychoneuroendocrinology. 2019 Oct;108:110-117. doi: 10.1016/j.psyneuen.2019.06.006. Epub 2019 Jun 12.
8
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.尸检后转录谱分析显示精神分裂症中炎症广泛增加:在与被诊断为精神分裂症、双相或重度抑郁障碍的患者相匹配的四联体对照中,比较前额叶皮层、纹状体和海马。
Transl Psychiatry. 2019 May 23;9(1):151. doi: 10.1038/s41398-019-0492-8.
9
Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia.首发精神病的外周生物标志物——来自精神分裂症神经炎症假说的机遇
Psychiatry Investig. 2019 Mar;16(3):177-184. doi: 10.30773/pi.2018.12.19.1. Epub 2019 Mar 7.
10
The S100B story: from biomarker to active factor in neural injury.S100B 蛋白的故事:从神经损伤的生物标志物到活性因子。
J Neurochem. 2019 Jan;148(2):168-187. doi: 10.1111/jnc.14574. Epub 2018 Nov 12.